INTRODUCTION: This Consensus Statement on Cervical Cancer was offered to the Australian and New Zealand Journal of Obstetrics and Gynaecology by the Communications Division of the National Institutes of Health (NIH). Bethesda, Maryland, United States of America. The NIH Consensus Program Information Service asked our help to disseminate what they believe to be useful information for our readers.

The report was prepared by a panel of experts who considered scientific evidence presented at a Consensus Development conference at NIH. It contains recommendations and conclusions concerning Cervical Cancer.

NIH consensus conferences bring together researchers, practising physicians, representatives of public interest groups, consumers, and others to carry out scientific assessments of drugs, devices, and procedures in an effort to evaluate their safety and effectiveness.

Our oncology reviewers considered that this Consensus Statement was appropriate for the Journal and provided table 1 so that the details of the FIGO staging would add meaning to the section on treatment.